• Most Popular
  • Most Shared

Akorn: FDA OKs tetanus diphtheria vaccine unit dose application

Mon Nov 26, 2007 9:55am EST

Stocks

   

Nov 26 (Reuters) - Pharmaceutical company Akorn Inc (AKRX.O) said the U.S. Food and Drug Administration approved a supplemental biologics license application for a unit dose, preservative-free tetanus diphtheria vaccine.

Stocks

Akorn, which has been marketing a multi-dose preserved version of the tetanus diphtheria vaccine since September, expects to launch the new vaccine in the first quarter of 2008, the company said. (Reporting by John Tilak in Bangalore; Editing by Jarshad Kakkrakandy)

Stocks


More from Reuters

Photo

Time Warner Cable, Fox at impasse; blackout looms

NEW YORK (Reuters) - About 13 million Time Warner Cable Inc subscribers will lose Fox programing at midnight unless the cable service provider reaches a last-minute deal to pay News Corp fees to broadcast the network's shows.

» More Top News
A picture of an arrow in this file photo. REUTERS/File
OUTLOOK 2010:

The coming Great Inflation

Real or imagined, Americans have plenty of things to worry about. Should inflation be one of them?  Full Article 

ECONOMY
REUTERS/Bernd Debusmann
Bernd Debusmann:

Killing people is easier than killing ideas

All the talk about hunting down those responsible for attacks on the U.S. has a familiar ring.  Commentary 

U.S.